https://www.selleckchem.com/products/n6f11.html
blished covariate relationships are described in detail. Preliminary reports have described significant procoagulant events in patients with coronavirus disease-2019 (COVID-19), including life-threatening pulmonary embolism (PE). We review the current data on the epidemiology, the possible underlying pathophysiologic mechanisms, and the therapeutic implications of PE in relation to COVID-19. The incidence of PE is reported to be around 2.6-8.9% of COVID-19in hospitalized patients and up to one-third of those requiring intensive care unit
Like
Comment
Share
